Selection of Resistant Bacteria at Very Low Antibiotic Concentrations by Gullberg, Erik et al.
Selection of Resistant Bacteria at Very Low Antibiotic
Concentrations
Erik Gullberg
1", Sha Cao
1", Otto G. Berg
2, Carolina Ilba ¨ck
1, Linus Sandegren
1, Diarmaid Hughes
1, Dan I.
Andersson
1*
1Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden, 2Department of Molecular Evolution, Uppsala University, Uppsala,
Sweden
Abstract
The widespread use of antibiotics is selecting for a variety of resistance mechanisms that seriously challenge our ability to
treat bacterial infections. Resistant bacteria can be selected at the high concentrations of antibiotics used therapeutically,
but what role the much lower antibiotic concentrations present in many environments plays in selection remains largely
unclear. Here we show using highly sensitive competition experiments that selection of resistant bacteria occurs at
extremely low antibiotic concentrations. Thus, for three clinically important antibiotics, drug concentrations up to several
hundred-fold below the minimal inhibitory concentration of susceptible bacteria could enrich for resistant bacteria, even
when present at a very low initial fraction. We also show that de novo mutants can be selected at sub-MIC concentrations of
antibiotics, and we provide a mathematical model predicting how rapidly such mutants would take over in a susceptible
population. These results add another dimension to the evolution of resistance and suggest that the low antibiotic
concentrations found in many natural environments are important for enrichment and maintenance of resistance in
bacterial populations.
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Introduction
Antibiotics represent one of mankind’s most important medical
inventions but during the last decades the continuing rapid
development of antibiotic resistance has emerged as one of the
most serious health care problems, both in community and
hospital settings [1,2,3]. Whereas some resistance-conferring genes
were most likely originally selected to serve metabolic functions
and/or for signal trafficking or protection against competing
antibiotic-producing bacteria [4], the recent worldwide enrich-
ment and spread of highly resistant pathogenic bacteria in the
micro-biosphere has largely been driven by human activities,
including the extensive use and misuse of antibiotics in human and
veterinary medicine and in agriculture [2,3,5,6,7]. While it is
evident that the high concentrations of antibiotics used therapeu-
tically can select for resistant mutants, it still remains unclear how
important the low antibiotic concentrations that due to anthro-
pogenic input pollute natural (e.g. aquatic or soil) environments
[8,9,10], that are produced naturally by antibiotic-producing
micro-organisms or that are present in certain human/animal
body compartments during therapeutic or growth promotion use,
are for the selection and enrichment of resistant mutants. In
pharmacodynamic models it is generally assumed that selection of
resistant bacteria only occurs at concentrations between the
minimal inhibitory concentration (MIC) of the susceptible wild
type population (MICsusc) and that of the resistant bacteria
(MICres) [11,12] (mutant selective window hypothesis, see Fig. 1A)
and that concentrations below the MICsusc will not inhibit growth
of the susceptible bacteria and therefore not be selective. Earlier
studies on selection with small differences in bacterial susceptibility
to antibiotics show that selection can efficiently act on minute
differences to select for resistance [13,14,15]. Furthermore, using
an elegant color-based assay a recent study has shown qualitatively
that levels of antibiotics below the MIC can enrich for resistant
bacteria [16]. Here, we further explore the mutant selective
window assumption and as outlined schematically in Fig. 1A, we
examine for two bacterial species and three antibiotics how far
below the MICsusc pre-existing and de novo generated resistant
mutants can be selectively enriched because of minute reductions
in the growth rate of their susceptible counterparts.
To determine if exposure to very low antibiotic concentrations
(,,MICsusc) can result in enrichment for resistant mutants, we
used several well-defined mutants of Escherichia coli and Salmonella
enterica (Var. Typhimurium LT2) (Table S1 in Text S1) and three
different classes of antibiotics with high importance to human and
veterinary medicine (tetracyclines, fluoroquinolones and amino-
glycosides). The resistance markers used were Tn10dTet (confers
tetracycline resistance), gyrA (S83L and D87N), DmarR, and DacrR
mutations (confer ciprofloxacin resistance) and rpsL (K42R)
(confers streptomycin resistance), all of which are found in clinical
isolates of several different bacterial species. Using highly sensitive
competition experiments between isogenic pairs of susceptible and
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 resistant strains, we show that selection of resistant bacteria can
occur at antibiotic concentrations far below the minimal inhibitory
concentration. Finally, we present a mathematical model, showing
how resistant mutants are expected to arise de novo and spread in
bacterial populations at these sub-MIC levels of antibiotics.
Results
An initial examination of the effect of low antibiotic concen-
trations was performed in single cultures where a susceptible wild-
type and a resistant mutant carrying a Tn10dTet were grown
separately in the presence of different concentrations of tetracy-
cline. As shown in Fig. 1B and Table S2 in Text S1,
concentrations far below MICsusc reduced the exponential growth
rate of the susceptible strain without any apparent effect on the
resistant strain. For example, at a concentration 1/30 of the
MICsusc, the susceptible strain grew about 15% slower than
without antibiotic whereas the resistant mutant seemed unaffected,
suggesting that resistant strains are strongly selected at these low
concentrations. To increase the sensitivity of these assays and
allow detection of extremely small differences in growth rates, we
performed competition experiments between pairs of susceptible
and resistant strains. The MICs for the susceptible and resistant
mutants were: S. typhimurium wild type (streptomycin=4 ug/ml,
tetracycline=1.5 ug/ml), rpsL K42R .1024 ug/ml and Tn10dTet
strain =128 ug/ml; E. coli wild type (ciprofloxacin=0.023 ug/ml),
gyrA S83L (ciprofloxacin=0.38 ug/ml), gyrA D87N (ciprofloxaci-
n=0.25 ug/ml), DacrR (ciprofloxacin=0.047 ug/ml) and DmarR
(ciprofloxacin=0.047 ug/ml). The strains were genetically tagged
with variants of the green fluorescent protein gene (yfp and cfp,
encoding yellow- and cyan-fluorescent proteins, respectively) to
allow counting of large populations of competing cells by
fluorescence activated cell sorting (FACS), thereby significantly
reducing any experimental errors associated with counting of small
populations. The competing strains were isogenic except for the
resistance determinant and the yfp and cfp genes producing the
respective fluorescent proteins. Control experiments showed that
the difference in fitness cost between the cfp and yfp markers had a
negligible impact on growth rates (Fig. S1). The strains were
competed for up to 80 generations by serial passage in batch
cultures in the presence of different concentrations of either one of
the antibiotics tetracycline, ciprofloxacin (a fluoroquinolone) and
streptomycin (an aminoglycoside) as well as in the absence of drug
(Fig. 2A–D, Fig. 3A–H, Fig. 4A–E). As shown by our previous
studies [17], this experimental set-up allows detection of growth rate
differences at least as small as 0.3%, which approaches the limit of
sensitivity set by the interference of periodic selection events.
Whereas the growth rate measurement shown in Fig. 1B only
measured the exponential phase of growth, the competition
experiments represent a composite of growth and survival in lag
phase, exponential phase and stationary phase that allows
examination of the whole growth cycle.
The data presented in Fig. 2A, C, Fig. 3A, C, E, G and Fig. 4A–
D shows how the ratio of resistant:susceptible strains changes as a
function of the number of generations of growth at different
concentrations of antibiotic. Each line represents one competition
experiment and the slope is a measure of the selection coefficient
(s-value). Thus, the negative slope obtained in the absence of
antibiotic is a measure of the fitness cost of the antibiotic resistance
mechanism and a positive slope indicates that the resistant mutant
is enriched. When the s-values obtained from these experiments
are plotted as a function of antibiotic concentration the intercept,
Figure 1. Growth rates as a function of antibiotic concentra-
tion. (A) Schematic representation of growth rates as a function of
antibiotic concentration. Green indicates a concentration interval where
the susceptible strain (blue line) will outcompete the resistant strain
(red line). Orange (sub-MIC selective window) and red (traditional
mutant selective window) indicate concentration intervals where the
resistant strain will outcompete the susceptible strain. MICsusc=
minimal inhibitory concentration of the susceptible strain, MICres=
minimal inhibitory concentration of the resistant strain and MSC=
minimal selective concentration. (B). Relative exponential growth rates
of susceptible (open circles) and resistant (closed circles) strains of S.
typhimurium as a function of tetracycline concentration. Standard errors
of the mean are indicated. A relative growth rate of 1.0 corresponds to
approximately 1.8 hr
21. Cells were grown in Mueller Hinton medium at
37uC.
doi:10.1371/journal.ppat.1002158.g001
Author Summary
Antibiotic resistance has emerged as a very significant
health care problem due to the extensive use and misuse
of antibiotics in human and veterinary medicine and in
agriculture. It remains unclear where most of the resistant
bacteria have been selected, and in particular if the low
antibiotic concentrations that are present in natural
environments or in human/animal body compartments
during therapeutic or growth promotion use, are impor-
tant for the selection and enrichment of resistant mutants.
The presented data shows that for several clinically used
antibiotics extremely low concentrations, similar to the
concentrations found in natural environments, can select
for resistant bacteria. These results suggest that antibiotic
release into the environment might be a significant
contributor to the emergence and maintenance of
resistance and emphasize the importance of introducing
measures to reduce antibiotic pollution.
Selection of Resistant Bacteria
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concentration (MSC) where the fitness cost of the resistance is
balanced by the antibiotic-conferred selection for the resistant
mutant (Fig. 2B, D, Fig. 3B, D, F, H and Fig. 4E). Depending on
the antibiotic and the type of resistance mutation examined the
MSC varied between 1/4 and 1/230 of the MICsusc. For
streptomycin the MSC value was 1/4 of the MIC value of the
susceptible strain (Fig. 2B), for tetracycline 1/100 (Fig. 2D) and for
ciprofloxacin it varied between 1/10 (Fig. 3B) and 1/230 (Fig. 3D)
of the MICsusc depending on the particular resistance mutation.
These values correspond to absolute antibiotic concentrations of
1 mg/ml (streptomycin), 15 ng/ml (tetracycline), and 2.5 ng/ml to
100 pg/ml (ciprofloxacin). The competitions performed with a
small initial fraction of resistant mutants also showed that the
selection coefficients are independent of the initial frequency of
resistant mutants. Even at initial frequencies as low as 10
24, the
same enrichment (i.e. same selection coefficient) of the resistant
mutants could be observed as at a 1:1 ratio (compare Figures 2D
and 4E).
Since the resistant mutants could be enriched from very low
initial fractions (10
24) we also tested whether resistant mutants
could be selected de novo from a susceptible population. To this end
we grew 20 independent lineages of a susceptible wild type
Salmonella typhimurium LT2 strain for 700 generations at 1/4 of the
MIC of streptomycin and continuously screened for resistant cells
by plating on different concentrations of streptomycin. At this low
level of antibiotic we could observe rapid enrichment of de novo
resistant mutants (Fig. 5). Thus, within 200 to 400 generations, a
considerable enrichment of mutants with resistances between 2
and 16 times the MIC of the starting strain (8–64 mg/ml) could be
seen, and after 500 to 600 generations also high-level resistant
mutants (24–32 times MIC of the wild type =96–128 mg/ml)
appeared. After 400 generations, all 20 lineages contained
subpopulations with a MIC higher than 32 mg/ml (8 times
MIC), and after 600 generations 14 of the lineages had
subpopulations with a MIC higher than 64 mg/ml (16 times
MIC). Using the method described above, 20 lineages of wild type
E. coli were grown for 600 generations in sub-MIC levels of
ciprofloxacin. After 500 generations of growth at 1/10 of the MIC,
five of the lineages had subpopulations (.1% of the population)
with low level resistance (2-fold higher MIC than the susceptible
parental strain) to ciprofloxacin, and after 600 generations, one
out of twenty lineages had a subpopulation of cells with an MIC 8-
fold higher than the susceptible parental strain (see Fig. S2).
We also calculated (Appendix in Text S1) how rapidly de novo
generated resistant mutants would take over in a susceptible
population at low antibiotic concentration, as determined by
mutation rates (u), population sizes (N), and the fitness advantage
(s) in the presence of antibiotics. s depends on the antibiotic
concentration above the MSC as shown in Fig. 2 and 3. When no
Figure 2. Competition experiments between susceptible and resistant strains, streptomycin and tetracycline. Competition
experiments at different concentrations of antibiotics (A (rpsL105 (K42R))a n dC( Tn10dtet), and calculated selection coefficients as a function of
antibiotic concentrations (B and D). Fig. A and C are each based on one single competition experiment (averages of four competitions), while Fig. B
and D are calculated from the selection coefficients of up to 20 competitions (Table S3 in Text S1). Standard errors of the mean are indicated.
doi:10.1371/journal.ppat.1002158.g002
Selection of Resistant Bacteria
PLoS Pathogens | www.plospathogens.org 3 July 2011 | Volume 7 | Issue 7 | e1002158Selection of Resistant Bacteria
PLoS Pathogens | www.plospathogens.org 4 July 2011 | Volume 7 | Issue 7 | e1002158resistance mutants are present initially, the time to fixation can be
expressed as
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The first term is the stochastic waiting time for the first surviving
mutant to appear and the second term is from the subsequent
growth to 50% presence. For small values of uN ,0.1, the first
term dominates and fixation may be slow. For large values, uN .1,
the second term dominates and fixation can be fast, ca. 100–1000
generations for s between 0.1–0.01 (Fig. 6). In this limit, resistance
mutants appear so frequently that it makes little difference to the
fixation time if they are present initially or not. In this context it is
worth noting that sub-MIC levels of several antibiotics, most
pronounced for fluoroquinolones, have been shown to increase
bacterial mutation rates which potentially could reduce the waiting
time and thereby increase the rate of mutant take-over [18].
Discussion
Antibiotic concentrations in natural environments can vary
extensively depending on the particular environment. For
example, in connection with polluting pharmaceutical industries
or at sewage outlets from hospitals the concentrations can reach
very high levels (mg/ml), with fluoroquinolones frequently
reaching the highest levels [19,20,21] whereas in aquatic
environments or in soil levels are typically much lower [8]. The
presented data suggests that even in those environments with very
low antibiotic concentrations, maintenance and selection of
resistant bacteria can occur. For example, the MSC for
ciprofloxacin and tetracycline obtained from our experiments
correspond to 100 pg/ml and 15 ng/ml, respectively, similar to
concentrations that can be found in some aquatic and soil
environments [8]. Thus, the surprisingly high frequencies of
antibiotic-resistant bacteria found in animals from relatively
pristine environments [22,23,24] could conceivably be partly
explained by enrichment due to sub-MIC selective effects.
These findings are also highly relevant with regard to the
question of reversibility of resistance. Since most antibiotic
resistance mechanisms are associated with a fitness cost it has
been proposed that the fitness costs of resistance will allow
susceptible bacteria to out-compete resistant bacteria if the
antibiotic selective pressure is reduced. However, most available
data suggests that the rate of reversibility will be slow or absent at
the community level [25]. Several factors could contribute to this
irreversibility, including the absence of a fitness cost, reduction of
the fitness cost through compensating mutations and genetic co-
selection between the resistance-conferring gene and another gene
under selection. In addition, the sub-MIC selection observed here
could be a significant contributor to this long-term persistence of
resistance where very low antibiotic concentrations in the
environment are sufficient to maintain the existing resistant
bacteria in the population by further balancing the fitness cost of
the resistance. This can be particularly important for bacterial
pathogens whose normal life cycle involves growth in soil
environments (e.g. P. aeruginosa) or periodic growth in aquatic
environments (e.g. E. coli).
From the slope of the graphs in Fig. 2B, D and Fig. 3B, D, F and
H we can infer that the fitness cost of the resistance mutation has a
major influence on the value of the MSC. This cost must first be
overcome by a negative effect of antibiotics on the susceptible
bacteria before resistant bacteria will be selected, shifting the MSC
towards higher concentrations. Reducing this cost will shift the
curve upwards and lower the MSC. It is also evident that the
increased resistance of the mutants (difference between MICsusc.
and MICres.) or the mode of resistance (point mutation or efflux
pumps) has little effect on MSC relative to the fitness cost. Since
our data was obtained in defined genetic backgrounds with single
point mutations or deletions commonly found for the antibiotics
tested, the fitness cost represents the cost of a de novo resistance
mutation. However, in most resistant strains found clinically the
fitness cost of resistance is frequently compensated for by
secondary mutations without a loss of resistance [25]. Such fitness
compensation has been described for resistance to many different
antibiotics including fluoroquinolones and streptomycin
[26,27,28]. This implies that the antibiotic concentrations at
which such compensated resistant strains will be selected can be
even lower than what we have measured here.
Another significant implication from our and the findings of
others is that the widely used concept of the mutant selective
window needs modification. Thus, in pharmacodynamics it is
generally assumed that antibiotic concentrations below the MIC
do not confer selection and that the mutant selective window—the
concentration range in which the resistant mutant is enriched—
extends between the MIC of the susceptible wild type and the
MIC of the resistant mutants [11,12]. However, our results imply
that the biologically relevant sub-MIC selective window is much
wider and needs to include antibiotic concentrations several
hundred-fold below MICsusc (Fig. 1A). Furthermore, the method-
ology described here could be used to probe the biologically active
antibiotic concentrations in different environments, including for
example animal models. Thus, by performing competitions
between genetically tagged susceptible and resistant strains in
animals treated with different antibiotic concentrations one can
from the enrichment rate of resistant bacteria infer the biologically
active concentration of antibiotic at the site of bacterial growth.
At selection above the MIC of a strain, the main driving force of
the selection is antibiotic resistance, while the fitness cost of the
mutation is less critical. Even mutations with a very high cost will
be selected, since competitors in the form of susceptible bacteria
will be eliminated. At sub-MIC levels, however, the situation is
different since the susceptible bacteria will not die, they will only
grow slower. Because of this, resistance mutations conferring high
fitness costs will not be enriched; only mutations where the fitness
cost is lower than the growth reduction caused by the antibiotic in
the susceptible bacteria will be competitive. This suggests that a
new spectrum of low-cost or no-cost resistance mutations might be
enriched during such conditions. The data in Fig. 5, show that
these sub-MIC levels of antibiotics do not only enrich for pre-
existing resistant mutants, but they can also select for resistant
mutants de novo from a susceptible population. It is interesting to
note that despite the low antibiotic concentrations used, mutants
with high resistance levels were enriched. Since the streptomycin
Figure 3. Competition experiments between susceptible and resistant strains, ciprofloxacin. Competition experiments at different
concentrations of ciprofloxacin (A (gyrA2 (D87N)), C (gyrA1 (S83L)), E (DacrR) and G (DmarR)) and calculated selection coefficients as a function of
antibiotic concentrations (B, D, F and H). Fig. A, C, E and G are each based on one single competition experiment (averages of three competitions),
while fig. B, D, F and H are calculated from the selection coefficients of 6 competitions (Table S3 in Text S1). Standard errors of the mean are indicated.
doi:10.1371/journal.ppat.1002158.g003
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the same as the MSC determined in the competitions between
wild type and an rpsL K42R mutant, the enriched resistant bacteria
are likely to carry resistance mutations with a fitness cost that is
significantly lower than the previously studied rpsL mutation.
In the presented experiments pre-existing mutants were rapidly
enriched in competitions with susceptible strains. From the
mathematical model we can infer a similar situation for de novo
resistant mutants, especially in large populations where uN .1 and
at antibiotic concentrations where 0.01, s ,1.0. In those
situations resistant mutants rapidly appear and within 100–1000
generations of growth they will take over the population. The
model is supported by the experiments shown in Fig. 5 and Fig.
S2, where de novo mutants continuously increased in frequency
during 600–700 generations of growth in the presence of sub-MIC
levels of antibiotics.
Figure 4. Competition experiments with low initial frequencies of resistant mutants. Competition experiments at different concentrations
of antibiotics and different starting fractions of resistant mutants. (A) Initial ratio of susceptible to resistant mutants 10:1. (B) Initial ratio of susceptible
to resistant mutants 10
2:1. (C) Initial ratio of susceptible to resistant mutants 10
3:1. (D) Initial ratio of susceptible to resistant mutants 10
4:1. (E)
Calculated selection coefficients as a function of antibiotic concentrations. Fig. A to D are each based on one single competition experiment while E is
calculated from the selection coefficients of 24 independent competitions with four different starting fractions of resistant mutants (Table S3 in Text
S1). Standard errors of the mean are indicated.
doi:10.1371/journal.ppat.1002158.g004
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antibiotic levels which are present in many natural environments
or generated in certain body compartments during treatment are
relevant for the enrichment and maintenance of pre-existing
resistant mutants as well as for the de novo selection of new mutants.
These results emphasize the importance of introducing measures
that reduce antibiotic levels in the environment and use of
treatment dosing regimens that preclude prolonged time periods of
sub-MIC levels of antibiotics.
Materials and Methods
Bacterial strains, genetic methods, and growth
conditions
Strains used in this study were derived from Escherichia coli
MG1655 and Salmonella enterica serovar Typhimurium LT2
(designated S. typhimurium in the text) and are listed in Table S1
in Text S1. The resistant strains were constructed by P22
transduction (S typhimurium) or P1 transduction (E coli) of the
resistance genes into the parental strains. The liquid and solid
media used for bacterial growth were Mueller–Hinton broth
(Becton Dickinson, MD, USA), Mueller–Hinton agar (Mueller–
Hinton broth supplemented with 1.5% agar) and Luria–Bertani
(LB) agar (Sigma-Aldrich, MO, USA). Strains were grown at
37uC, and liquid cultures were aerated by shaking.
Growth rate measurements
Growth rates were measured at 37uC in Mueller-Hinton broth,
with or without tetracycline present, using a Bioscreen C Analyzer
(Oy Growth Curves Ab Ltd, Helsinki, Finland). Each well was
inoculated with a 1000-fold dilution of an overnight culture and
measurements at each antibiotic concentration were made in
quadruplicate. The cultures were grown for 24 hours with
continuous shaking, and OD600 measurements were taken every
4 min. The calculations were based on OD600 values between 0.02
and 0.1, where growth was observed to be exponential. The
sensitive strain (DA6192) and the resistant strain (DA17822) were
grown in separate experiments, and the relative growth rates were
calculated as the derived growth rates divided by the growth rate
of the same strain grown without antibiotics.
MIC measurements
MIC assays of tetracycline and ciprofloxacin were performed by
broth macrodilution in 10 mL tubes. Tubes containing Mueller-
Hinton broth (1 mL) supplemented with different concentrations
of antibiotics were inoculated with 1 mL of an overnight bacterial
Figure 5. Selection of de novo resistant mutants at sub-inhibitory concentrations of antibiotics. A total of 20 independent lineages of S.
typhimurium were serially passaged in Mueller-Hinton medium containing 1 mg/ml streptomycin. Every 100 generations approximately 10
5 cells were
plated onto LB agar containing different concentrations of streptomycin and the fractions of resistant mutants were calculated. The data points are
grouped by number of generations of growth and resistance level, and in each of these data sets one data point represents the fraction of cells
present in one lineage capable of growth at the specified antibiotic concentrations. Please note that data points at the baseline will overlap.
doi:10.1371/journal.ppat.1002158.g005
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shaking for 16 to 18 hours, the tetracycline cultures protected from
light to avoid degradation of the antibiotic. The MIC was set to
the lowest concentration of antibiotic yielding no visible growth.
The MIC of streptomycin was determined by Etest according to
the instructions of the manufacturer (AB bioMerieux, Solna,
Sweden). Etests were performed on Mueller-Hinton agar plates
incubated for 16–18 h at 37uC.
Competition experiments
Limited sampling of competitors (,10
3 cells) commonly
introduces statistical uncertainties in competition experiments
and more accurate measurements of resistant mutant to wild type
cell ratios can be obtained with the aid of chromosomal copies of
either the cyan (cfp) or yellow (yfp) variants of green fluorescent
protein gene (gfp). These allow tracking of large numbers of single
cells (10
5 cells) using a fluorescence activated cell sorter (FACS).
The cfp/yfp genes were inserted into galK using the l Red system as
previously described [29] and moved by phage P22 transduction
or phage P1 transduction into the various strains.
Overnight cultures grown in Mueller-Hinton medium of the
susceptible wild type strains with either cfp or yfp, were mixed 1:1,
10:1, 10
2:1, 10
3:1 and 10
4:1 with the isogenic resistant mutant
carrying the other marker and maintained by 1000-fold serial
dilution (resulting in 10 generations of growth per serial passage)
every 24 hours for up to 4 to 6 serial passages. The ratio of
resistant to susceptible cells in the population was determined at
each serial passage by counting 10
5 cells using a fluorescence-
activated cell sorter (BD FacsAria). The selection coefficients were
determined using the regression model s = [ln(R(t)/R(0))]/[t], as
previously described [30] where R is the ratio of resistant to
susceptible. This protocol allowed reproducible determinations of
fitness differences as small as s =0.003 [17]. Two independently
constructed sets of each wild type strain, marked with either cfp or
yfp, were also included to measure the relative impact on growth
rates of having a cfp marker compared to yfp. These control
experiments showed that over 40 generations of competition, the
difference in cost between the markers had a negligible impact on
growth rates. (Fig. S1). The competition experiments performed
with a low initial fraction of resistant mutants were done with
tetracycline due to the long time required for the appearance of de
novo tetracycline resistant mutants that might disturb the
competition experiments.
Enrichment of de novo evolved resistant mutants
To investigate whether sub-inhibitory antibiotic concentration
could also select for de novo generated resistant mutants, susceptible
bacteria was serially passaged at 1/4 of the MIC of streptomycin
and at 1/10 of the MIC of ciprofloxacin. A total of 20 independent
lineages of S. typhimurium LT2 was serially passaged by 1000-fold
dilution in 1 ml batch cultures every 24 hours for 700 generations
(10 generations of growth per serial passage) in Mueller-Hinton
medium containing 1 mg/ml streptomycin, and 20 independent
lineages of E. coli MG1655 were serially passaged by 1000-fold
dilution in1 mlbatchculturesevery24 hoursfor600generationsin
Mueller-Hinton medium containing 2.3 ng/ml ciprofloxacin. The
lineages were started from overnight cultures from independent
colonies, using an initial bottleneck of approximately 10
4 cells to
minimize the number of preexisting resistant mutants. The
percentage of resistant cells in each culture was monitored by
plating approximately 10
5 cells onto LB agar containing different
concentrationsofantibioticsevery100generationsandcountingthe
number of colonies. A subset of these cells were restreaked on the
same antibiotic concentration to confirm that they were resistant.
Accession numbers
Tn10 (Transposon Tn10 tetracycline resistance and repressor
genes tetA and tetR)
GenBank: J01830.1
rpsL (30S ribosomal protein S12)
GenBank: AAL22311.1
Swiss-Prot: P0A7S6
gyrA (DNA gyrase subunit A)
GenBank: AAC75291.1
Swiss-Prot: P0AES4
acrR (HTH-type transcriptional regulator AcrR)
GenBank: AAC73566.1
Swiss-Prot: P0ACS9
marR (Multiple antibiotic resistance protein MarR)
GenBank: AAC74603.2
Figure 6. Fixation time for adaptive mutations. (A) 50%
penetration time as function of selection coefficient when no mutants
are present initially for N=10
7 and, from top to bottom, u=10
29,1 0
28,
10
27, and 10
26. Red lines are from Eq. (4) and the crosses from the
stochastic model, Eqs. (7) – (10), with m0 =0. (B). 50% penetration time
as function of the selection coefficient when the initial presence of
mutantsis determined by mutation-selection balance, m0 = Nf0 = uN/|s0|.
Resultsarefors0 = 20.02,N=10
7and, from top tobottom, u=10
26,1 0
27,
10
28. The red lines are from Eq. (6), and the crosses are from the stochastic
model, Eqs. (7) – (10).
doi:10.1371/journal.ppat.1002158.g006
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gfp (Green fluorescent protein)
GenBank: AAA27722.1
Swiss-Prot: P42212
Supporting Information
Figure S1 Competition experiments between two wild type S
typhimurium strains marked with either yfp or cfp (strains DA15110
and DA15111, Table S1 in Text S1). Each line represents one
experiment (averages of four competitions), and a total of four
independent experiments were conducted.
(TIF)
Figure S2 Selection of de novo resistant mutants at sub-inhibitory
concentrations of antibiotics. A total of 20 independent lineages of
E. coli MG1655 were serially passaged in Mueller-Hinton medium
containing 2.3 ng/ml ciprofloxacin. Every 100 generations
approximately 10
5 cells were plated onto LB agar containing
different concentrations of ciprofloxacin and the fractions of
resistant mutants were calculated. The data points are grouped by
number of generations of growth and resistance level, and in each
of these data sets one data point represents the fraction of cells
present in one lineage capable of growth at the specified antibiotic
concentrations. Please note that data points at the baseline will
overlap.
(TIF)
Text S1 Contains Table S1 (genotypes and MICs of strains),
Table S2 (exponential growth rate data), Table S3 (competition
data) and Appendix (fixation time for an adaptive mutation).
(DOC)
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